Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • World
  • Users
  • Groups
Skins
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (Zephyr)
  • No Skin
Collapse
Peptide Critic Community

Peptide Critic Community

  1. Randy the Rats Research Forum
  2. Peptide Discussion
  3. Going from TB-500 to TB4.
Prize
Enter to Win a Gansulin Auto Injector Pen, with Carts a Pepboys Vial Storage Case
Ends in
5169 entries · 1000 participants
Enter →

Going from TB-500 to TB4.

Scheduled Pinned Locked Moved Peptide Discussion
tb-500thymosin-beta-4cartalax
1 Posts 1 Posters 100 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • J Offline
    J Offline
    Juan Doe
    wrote last edited by
    #1

    Currently in my 4-8 weeks break time away from research.

    Last research cycle, TB-500 was administered every 5 days @5mg at a time.
    For the next research cycle, would the TB4 dosage stay the same as TB-500?

    Additional peps were BPC-157 .5mg twice per day, mots-c 5mg every 5 days, copper 2mg daily and Reta every Saturday 1mg and went up weekly and currently @5mg. This Saturday will start titrating off by reducing by 1-2mg per week.

    Do plan to add cartalax if I can find it.
    Would actually like to do it during my current off week but can’t seem to find a kit with good COAs.

    Thoughts would be appreciated

    1 Reply Last reply
    0
    Reply
    • Reply as topic
    Log in to reply
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes


    • Login

    • Login or register to search.
    • First post
      Last post
    0
    • Categories
    • Recent
    • Tags
    • Popular
    • World
    • Users
    • Groups